HPV-RELATED CARCINOMA
Clinical trials for HPV-RELATED CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV-RELATED CARCINOMA trials appear
Sign up with your email to follow new studies for HPV-RELATED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Healthy donors vaccinated against HPV to help fight cancer in transplant patients
Disease control ENROLLING_BY_INVITATIONThis study enrolls healthy relatives of patients with advanced HPV-related head and neck cancer. Donors receive a therapeutic HPV vaccine to boost their immune cells against HPV. These cells are then collected and used in a separate transplant or cell infusion to treat the patien…
Matched conditions: HPV-RELATED CARCINOMA
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 26, 2026 08:26 UTC
-
Tailored radiation aims to tame tough throat cancer with fewer side effects
Disease control OngoingThis study tests a personalized radiation approach for people with advanced HPV-related throat cancer that is at high risk of coming back. About 19 participants will receive radiation boosted to the exact tumor shape using special scans, aiming to keep the cancer under control wh…
Matched conditions: HPV-RELATED CARCINOMA
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:26 UTC
-
New combo therapy shows promise against HPV-Driven cancers
Disease control OngoingThis study tests a combination of two drugs, TG4001 and avelumab, in people with advanced cancers caused by HPV-16. The goal is to see if the combination can shrink tumors or slow disease progression better than avelumab alone. About 143 adults with cervical, anal, penile, or vul…
Matched conditions: HPV-RELATED CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Transgene • Aim: Disease control
Last updated May 26, 2026 08:18 UTC
-
Custom immune cells take on Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a personalized cell therapy called T-Plex for people with advanced solid tumors that have not responded to standard treatments. The therapy uses a patient's own immune cells, engineered to recognize and attack cancer cells. The main goal is to check s…
Matched conditions: HPV-RELATED CARCINOMA
Phase: PHASE1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 08:17 UTC
-
New HPV cancer drug trial seeks safe dose
Disease control OngoingThis early-stage trial tests a drug called IBRX-042 in 12 adults with HPV-related cancers that have come back or worsened. The main goal is to find the safest dose and see what side effects occur. Participants get three injections, one every three weeks, and are closely monitored…
Matched conditions: HPV-RELATED CARCINOMA
Phase: PHASE1 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Blood test may sniff out hidden throat cancer
Diagnosis OngoingThis study is testing whether a blood test (NavDx®) can find early signs of HPV-related oropharyngeal cancer by looking for tiny bits of HPV DNA in the bloodstream. Researchers are enrolling 9 people aged 45 and older with multiple sexual partners to see how many cases the test c…
Matched conditions: HPV-RELATED CARCINOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated May 19, 2026 12:00 UTC